Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7801
Invesco KBW High Dividend Yield Financial ETF
KBWD
$431M
| $558K | ﹤0.01% |
+33,707
| New | +$510K |
|
|
PETQ
7802
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $558K | ﹤0.01% |
14,500
-11,600
| -44% | -$359K |
|
|
DISCK
7803
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $558K | ﹤0.01% |
21,300
+9,000
| +73% | +$197K |
|
|
LX
7804
PUT
LexinFintech Holdings
LX
$224M
| $557K | ﹤0.01% |
83,200
+28,800
| +53% | +$206K |
|
|
MGIC
7805
DELISTED
Magic Software Enterprises
MGIC
| $557K | ﹤0.01% |
35,584
-15,311
| -30% | -$220K |
|
|
TAEQ
7806
DELISTED
Trend Aggregation U.S. ETF
TAEQ
| $557K | ﹤0.01% |
21,390
+3,666
| +21% | +$99.7K |
|
7807
CALL
KALA BIO
KALA
$18.3M
| $556K | ﹤0.01% |
33
+13
| +65% | +$245K |
|
|
LOVE
7808
PUT
LoveSac
LOVE
$253M
| $556K | ﹤0.01% |
12,900
-9,700
| -43% | -$320K |
|
7809
Mustang Bio
MBIO
$4.5M
| $556K | ﹤0.01% |
196
-91
| -32% | -$218K |
|
7810
CALL
Neurogene
NGNE
$723M
| $556K | ﹤0.01% |
+1,970
| New | +$481K |
|
7811
PUT
PROG Holdings
PRG
$1.7B
| $555K | ﹤0.01% |
+10,300
| New | +$532K |
|
|
RDUS
7812
PUT
DELISTED
Radius Health, Inc.
RDUS
| $555K | ﹤0.01% |
31,100
+18,600
| +149% | +$279K |
|
|
HI
7813
PUT
DELISTED
Hillenbrand
HI
| $553K | ﹤0.01% |
13,900
-14,300
| -51% | -$494K |
|
7814
CALL
Rhythm Pharmaceuticals
RYTM
$7.95B
| $553K | ﹤0.01% |
18,600
+1,100
| +6% | +$28K |
|
|
PRMW
7815
DELISTED
Primo Water Corporation
PRMW
| $553K | ﹤0.01% |
35,298
-13,677
| -28% | -$202K |
|
|
BLD
7816
PUT
DELISTED
TopBuild
BLD
| $552K | ﹤0.01% |
3,000
-5,700
| -66% | -$1.01M |
|
7817
Cytosorbents Corp
CTSO
$25.1M
| $552K | ﹤0.01% |
69,206
-60,597
| -47% | -$507K |
|
|
AVID
7818
PUT
DELISTED
Avid Technology Inc
AVID
| $552K | ﹤0.01% |
34,800
+8,300
| +31% | +$92.9K |
|
7819
PUT
Barclays
BCS
$94.7B
| $551K | ﹤0.01% |
68,900
-22,800
| -25% | -$153K |
|
|
CSR
7820
PUT
Centerspace
CSR
$938M
| $551K | ﹤0.01% |
7,800
+1,900
| +32% | +$134K |
|
7821
PUT
Spyre Therapeutics
SYRE
$9.14B
| $551K | ﹤0.01% |
+2,800
| New | +$580K |
|
|
LSLT
7822
DELISTED
Pacer Salt Low truBeta US Market ETF
LSLT
| $551K | ﹤0.01% |
19,121
+2
| +0% | +$56 |
|
7823
PUT
Ares Management
ARES
$32.5B
| $550K | ﹤0.01% |
11,700
-30,100
| -72% | -$1.36M |
|
7824
Carter's
CRI
$1.42B
| $550K | ﹤0.01% |
5,847
-119,518
| -95% | -$10.5M |
|
7825
CALL
Energy Recovery
ERII
$426M
| $550K | ﹤0.01% |
40,300
+21,400
| +113% | +$228K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.